health · HHS-NIH11
Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-27-011
Total Program Funding
$10.0M
Expected Awards
1
Deadline
September 28, 2026
GRANTQUICK SUMMARYPlain-English Overview
NIH/NINDS is making a SINGLE directed award of $10M to Massachusetts General Hospital to continue studying how vascular disease after stroke contributes to cognitive impairment and dementia. This is a non-competitive renewal — it's going to one named institution.
Who Should Apply
Massachusetts General Hospital only (named in the NOFO as the sole eligible institution under the original RFA-NS-19-012 award).
Who Should NOT Apply
Everyone else — this is a directed, non-competitive, single-source award.
Key Requirements (Plain English)
- •Must be the original awardee from RFA-NS-19-012
- •Must be Massachusetts General Hospital
- •$10M single source award
- •Non-competitive
💡 GrantQuick Tip
Don't apply — this is directed to MGH. It appears on Grants.gov because transparency rules require posting, but the recipient is predetermined.
Competitiveness: N/A — non-competitive, directed award.
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Total Program Funding
- $10.0M
- Expected Number of Awards
- 1
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Agency Contact
NINDS DCR ADRD Program Staff NINDS_DCR_ADRD_mail@mail.nih.gov
NINDS_DCR_ADRD_mail@mail.nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov